Literature DB >> 20139426

A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1.

Kiyonori Miura1, Shoko Miura, Koh-Ichiro Yoshiura, Stephanie Seminara, Daisuke Hamaguchi, Norio Niikawa, Hideaki Masuzaki.   

Abstract

Fibroblast growth factor receptor 1 (FGFR1) is one of the causative genes for Kallmann syndrome (KS), which is characterized by isolated hypogonadotropic hypogonadism with anosmia/hyposmia. The third immunoglobulin-like domain (D3) of FGFR1 has the isoforms FGFR1-IIIb and FGFR1-IIIc, which are generated by alternative splicing of exons 8A and 8B, respectively. To date, the only mutations to have been identified in D3 of FGFR1 are in exon 8B. We performed mutation analysis of FGFR1 in a 23-year-old female patient with KS and found a missense mutation (c.1072C>T) in exon 8A of FGFR1. The c.1072C>T mutation was not detected in her family members or in 220 normal Japanese and 100 Caucasian female controls. No mutation in other KS genes, KS 1, prokineticin-2, prokineticin receptor-2 and FGF-8 was detected in the affected patient or in her family members. Therefore, this is the first case of KS carrying a de novo missense mutation in FGFR1 exon 8A, suggesting that isoform FGFR1-IIIb, as well as isoform FGFR1-IIIc, plays a crucial role in the pathogenesis of KS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139426      PMCID: PMC4560031          DOI: 10.1093/humrep/deq006

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain.

Authors:  H D Beer; L Vindevoghel; M J Gait; J M Revest; D R Duan; I Mason; C Dickson; S Werner
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.

Authors:  Catherine Dodé; Jacqueline Levilliers; Jean-Michel Dupont; Anne De Paepe; Nathalie Le Dû; Nadia Soussi-Yanicostas; Roney S Coimbra; Sedigheh Delmaghani; Sylvie Compain-Nouaille; Françoise Baverel; Christophe Pêcheux; Dominique Le Tessier; Corinne Cruaud; Marc Delpech; Frank Speleman; Stefan Vermeulen; Andrea Amalfitano; Yvan Bachelot; Philippe Bouchard; Sylvie Cabrol; Jean-Claude Carel; Henriette Delemarre-van de Waal; Barbara Goulet-Salmon; Marie-Laure Kottler; Odile Richard; Franco Sanchez-Franco; Robert Saura; Jacques Young; Christine Petit; Jean-Pierre Hardelin
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

3.  Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis.

Authors:  Catherine Dodé; Corinne Fouveaut; Geert Mortier; Sandra Janssens; Jérôme Bertherat; Jacques Mahoudeau; Marie-Laure Kottler; Christine Chabrolle; Antoine Gancel; Inge François; Koen Devriendt; Slawomir Wolczynski; Michel Pugeat; Alfons Pineiro-Garcia; Arnaud Murat; Philippe Bouchard; Jacques Young; Marc Delpech; Jean-Pierre Hardelin
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

4.  Sex differences in odor identification ability: a cross-cultural analysis.

Authors:  R L Doty; S Applebaum; H Zusho; R G Settle
Journal:  Neuropsychologia       Date:  1985       Impact factor: 3.139

5.  PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.

Authors:  Carine Monnier; Catherine Dodé; Ludovic Fabre; Luis Teixeira; Gilles Labesse; Jean-Philippe Pin; Jean-Pierre Hardelin; Philippe Rondard
Journal:  Hum Mol Genet       Date:  2008-09-29       Impact factor: 6.150

6.  Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.

Authors:  Naoko Sato; Noriyuki Katsumata; Masayo Kagami; Tomonobu Hasegawa; Naoaki Hori; Setsuyo Kawakita; Shigeru Minowada; Aki Shimotsuka; Yoshimasa Shishiba; Masato Yokozawa; Toshiyuki Yasuda; Keisuke Nagasaki; Daiichiro Hasegawa; Yukihiro Hasegawa; Katsuhiko Tachibana; Yasuhiro Naiki; Reiko Horikawa; Toshiaki Tanaka; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos.

Authors:  J Partanen; L Schwartz; J Rossant
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

8.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

Authors:  John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules.

Authors:  R Legouis; J P Hardelin; J Levilliers; J M Claverie; S Compain; V Wunderle; P Millasseau; D Le Paslier; D Cohen; D Caterina
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

Review 10.  Genetic insights into human isolated gonadotropin deficiency.

Authors:  Ericka Barbosa Trarbach; Leticia Gontijo Silveira; Ana Claudia Latronico
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

View more
  1 in total

1.  Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.

Authors:  Eeva-Maria Laitinen; Kirsi Vaaralahti; Johanna Tommiska; Elina Eklund; Mari Tervaniemi; Leena Valanne; Taneli Raivio
Journal:  Orphanet J Rare Dis       Date:  2011-06-17       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.